One of my goals for the company over the next 12 months is they actually get to keep the same sales team in place for more than five minutes. Its a bit worrying the high turnover of sales reps. Perhaps its another tool at the disposal of incumbents competing with Admedus? To steal our sales reps? Was I the only one to be a little surprised when WP mentioned they were training up a new batch in the US? I thought the US team was stable.
Admedus Immunotherapy Deal, page-84
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.035(0.19%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.65 | $75.19K | 4.184K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 414 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |